Lupin gets USFDA nod to market generic version of Cipro

Lupin said it has received US health regulator USFDA'S approval to market a generic version of Bayer's Cipro, used to treat infections, in the American market.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news